GUIDED THERAPEUTICS INC (GTHP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250K 500K 750K Q3 '24: 0 Q4 '24: 1K Q1 '25: 0 Q2 '25: 117K Q3 '25: 60K Q4 '25: 590K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-200K 0 200K 400K 600K Q3 '24: 0 Q4 '24: -2K Q1 '25: 0 Q2 '25: 79K Q3 '25: 35K Q4 '25: 458K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-900K -600K -300K 0 300K 600K 900K Q3 '24: -561K Q4 '24: -534K Q1 '25: -414K Q2 '25: -763K Q3 '25: -485K Q4 '25: -710K Q1 '26: -302K Q2 '26: -478K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '24: -654K Q4 '24: -652K Q1 '25: -427K Q2 '25: -811K Q3 '25: -742K Q4 '25: -1.2M Q1 '26: -500K Q2 '26: -605K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 50K 100K 150K Q3 '24: 0 Q4 '24: 3K Q1 '25: 0 Q2 '25: 38K Q3 '25: 25K Q4 '25: 132K Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '24: -473K Q4 '24: -332K Q1 '25: -331K Q2 '25: -169K Q3 '25: -277K Q4 '25: -291K Q1 '26: -617K Q2 '26: -319K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '22: -615K Q4 '22: -342K Q1 '23: -499K Q2 '23: -438K Q3 '23: -473K Q4 '23: -336K Q4 '24: -332K Q4 '25: -291K Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q4 '24 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '24: 54.8M Q2 '24: 56M Q3 '24: 57M Q1 '25: 68.3M Q2 '25: 78.8M Q3 '25: 81.7M Q1 '26: 88.8M Q2 '26: 96.5M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.18 -0.12 -0.06 0.00 0.06 0.12 0.18 Q3 '22: -0.16 Q4 '22: -0.16 Q1 '25: -0.05 Q2 '25: -0.05 Q3 '25: -0.05 Q4 '25: -0.04 Q1 '26: -0.04 Q2 '26: -0.04 Q3 '22 Q4 '22 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.